GlassScriptPhysician profile
Andrew Albert Robitaille
NPI 1174183438
$12,683.54
in general payments reported to CMS, 2019-2025
22 companies · $916 in 2025
The $916 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $511 · 2021: $1,334 · 2022: $6,138 · 2023: $1,670 · 2024: $1,737 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,659 · Travel and Lodging: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,659.47 |
| Travel and Lodging | $1,663.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,332.41 | 2019-2025 | Citrefix, Prostep, Ortholoc 3di |
| Acumed LLC | $1,320.00 | 2022 | |
| Pinnacle, INC | $1,290.19 | 2019-2022 | |
| Osteomed LLC | $736.10 | 2020-2022 | |
| Medical Device Business Services, INC. | $554.30 | 2019-2021 | |
| Paragon 28, INC. | $419.74 | 2020-2025 | Mtp, Baby Gorilla |
| Medwest Associates | $394.16 | 2023 | |
| Treace Medical Concepts, INC. | $383.63 | 2022-2025 | |
| Depuy Synthes Sales INC. | $302.83 | 2019-2021 | |
| Arthrex, INC. | $206.40 | 2023 | |
| Bioventus LLC | $154.99 | 2019-2023 | |
| Smith+Nephew, INC. | $143.37 | 2019-2022 | |
| Boston Scientific Corporation | $129.83 | 2024 | |
| Horizon Therapeutics Plc | $127.64 | 2021-2022 | |
| Heron Therapeutics, INC. | $39.37 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $33.42 | 2023 | Senza |
| Integra Lifesciences Corporation | $23.91 | 2022 | |
| Mimedx Group, INC. | $22.57 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.62 | 2022 | |
| Orthofix Medical, INC. | $19.49 | 2024-2025 | Physio-Stim |
| Baxter Healthcare | $16.27 | 2025 | Perclot |
| Zimmer Biomet Holdings, INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Robitaille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.